Efficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Phase 2 Trial Efficacy and Safety of Rifaximinfor Patients With Chronic Intestinal Pseudo-obstruction: a Phase 2 T ...
Efficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Single Center, Randomized, Placebo Controlled, Double-blind Phase 2 Trial Efficacy and Safety of Rifaximinfor Patients With Chronic Intestinal Pseudo-obstruction: a Single Ce ...
Efficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Phase 2 Trial Efficacy and Safety of Rifaximinfor Patients With Chronic Intestinal Pseudo-obstruction: a Phase 2 T ...
Efficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Phase 2 Trial Efficacy and Safety of Rifaximinfor Patients With Chronic Intestinal Pseudo-obstruction: a Phase 2 T ...
Two tablets of the investigational product per dosing (400 mg of rifaximin) or the placebo are orally administered 3 times daily for 4 weeks. Two tablets of the investigational product per dosing (400 mg of rifaximin) or the placebo are orall ...